Belotecan
ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
Also known as: belotecan hydrochloride, camtobell, CKD-602, CKD602
Data last refreshed: (DrugCentral release 2024-11-01)
Key facts
Belotecan is a drug catalogued in DrugCentral. It was first approved by the Korean Food and Drug Administration (KFDA) in 2003. DrugCentral lists 1 molecular target, including TOP1. Recorded indications include Malignant tumor of ovary and Non-small cell lung cancer.
- Molecular targets: TOP1 (1 listed in DrugCentral).
- Indications: Malignant tumor of ovary and Non-small cell lung cancer.
- ATC code: L01CE04 (Topoisomerase 1 (TOP1) inhibitors).
- Molecular formula: C25H27N3O4; molecular weight 433.51 g/mol.
Indications & contraindications
Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).
Indications (2)
- Malignant tumor of ovary
- Non-small cell lung cancer
Mechanism & targets
Molecular targets (1)
| Target | Gene | Action | Activity |
|---|---|---|---|
| DNA topoisomerase 1 | TOP1 | inhibitor | IC50 6.56 |
Regulatory approvals (1)
| Date | Agency | Marketed as | Applicant | Orphan |
|---|---|---|---|---|
| 2003-12-10 | Korean Food and Drug Administration (KFDA) | — | Chong Kun Dang |
ATC classification
| ATC code | Therapeutic hierarchy |
|---|---|
L01CE04 | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS › ANTINEOPLASTIC AGENTS › PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS › Topoisomerase 1 (TOP1) inhibitors |
Chemical structure
Full physicochemical, ADMET and 3D-structure analysis of Belotecan is on its molecule page.
| Molecular formula | C25H27N3O4 |
|---|---|
| Molecular weight | 433.51 g/mol |
| CAS number | 256411-32-2 |
| InChIKey | LNHWXBUNXOXMRL-VWLOTQADSA-N |
| PubChem CID | 6456014 |
Frequently asked questions
Answers are generated from the structured data on this page, not written by hand.
What is Belotecan used for?
DrugCentral lists the following indications for Belotecan: Malignant tumor of ovary and Non-small cell lung cancer.
How does Belotecan work?
Its molecular targets in DrugCentral include TOP1 (inhibitor).
When was Belotecan first approved?
Belotecan was first approved by the Korean Food and Drug Administration (KFDA) in 2003.
What is the chemical formula of Belotecan?
Belotecan has the molecular formula C25H27N3O4 and a molecular weight of 433.51 g/mol.
Browse: all drugs starting with B · drug guides by category · protein targets A–Z.
Sources
- DrugCentral drug card 296 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
- ChEMBL CHEMBL2107315 — compound record and bioactivity
- PubChem CID 6456014 — chemical identifiers
- DrugBank DB12459 — drug record
- FDA UNII 27Z82M2G1N — substance identity
- UniProt P11387 (TOP1) — target protein
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.